Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Agnès Linglart Anya Rothenbuhler |
| Publication date | August 15, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |